Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Dohr

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
MMW Fortschritte Der Medizin|July 27, 2000
[Radiotherapy for tumor pain. Long-term freedom from pain with minimal side-effects]D Dohr, E M Röttinger
Laryngo- Rhino- Otologie|October 25, 2002
[Functional results succeeding primary combined external radiotherapy and brachytherapy for head and neck tumors]M Scheithauer, D Dohr, H Riechelmann
HNO|February 10, 2021
[Laser Doppler vibrometric measurements on human temporal bones]S P Schraven, D Dohr, N M Weiss, et al.
Bone Marrow Transplantation|August 10, 2000
CD34+ selected cells in mismatched stem cell transplantation: a single centre experience of haploidentical peripheral blood stem cell transplantationD Bunjes, C Duncker, M Wiesneth, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2000
Radioimmunotherapy for the intensification of conditioning before stem cell transplantation: differences in dosimetry and biokinetics of 188Re- and 99mTc-labeled anti-NCA-95 MAbsJ Kotzerke, G Glatting, U Seitz, et al.
Bone Marrow Transplantation|June 29, 2000
Non-infectious lung complications are closely associated with chronic graft-versus-host disease: a single center study of incidence, risk factors and outcomeC Duncker, D Dohr, S Harsdorf, et al.
Blood|July 27, 2001
Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II studyD Bunjes, I Buchmann, C Duncker, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
MMW Fortschritte Der Medizin|July 27, 2000
[Radiotherapy for tumor pain. Long-term freedom from pain with minimal side-effects]D Dohr, E M Röttinger
Laryngo- Rhino- Otologie|October 25, 2002
[Functional results succeeding primary combined external radiotherapy and brachytherapy for head and neck tumors]M Scheithauer, D Dohr, H Riechelmann
HNO|February 10, 2021
[Laser Doppler vibrometric measurements on human temporal bones]S P Schraven, D Dohr, N M Weiss, et al.
Bone Marrow Transplantation|August 10, 2000
CD34+ selected cells in mismatched stem cell transplantation: a single centre experience of haploidentical peripheral blood stem cell transplantationD Bunjes, C Duncker, M Wiesneth, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2000
Radioimmunotherapy for the intensification of conditioning before stem cell transplantation: differences in dosimetry and biokinetics of 188Re- and 99mTc-labeled anti-NCA-95 MAbsJ Kotzerke, G Glatting, U Seitz, et al.
Bone Marrow Transplantation|June 29, 2000
Non-infectious lung complications are closely associated with chronic graft-versus-host disease: a single center study of incidence, risk factors and outcomeC Duncker, D Dohr, S Harsdorf, et al.
Blood|July 27, 2001
Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II studyD Bunjes, I Buchmann, C Duncker, et al.
Pageof 1